Results 151 to 160 of about 14,935 (222)

Genomic innovation in precision oncology: integrated CRISPR-TTP bioengineering architecture for Ewing Sarcoma (version 4.0 - complete architectural specification). [PDF]

Front Genet
Burlai AM.
europepmc   +1 more source

Rare manifestations of pediatric chronic myeloid leukemia: a case report on priapism and a literature Review. [PDF]

Front Oncol
Budair R, Baqain L, Rihani R.
europepmc   +1 more source

Impact of Leukapheresis and Biological Risk Markers on Early Mortality in Patients with Hyperleukocytic Acute Myeloid Leukemia. [PDF]

Medicina (Kaunas)
Čučaković M, Trajković L, Dinić M, Pantić N, Sabljić N, Pravdić Z, Rajić J, Milošević V, Mitrović M, Vidović A, Suvajdžić-Vuković N, Bogdanović A, Jaković L, Virijević M.   +13 more
europepmc   +1 more source

Is It Time to Consider Hydroxyurea as a Potential Therapeutic Option in the Management of Malignant Pertussis - A Case Report and Literature Review. [PDF]

Cureus
Alsharif AI, Alatawi YD, Alanazi AMM.
europepmc   +1 more source

A Hyperacute Presentation of Small Cell, Non-Nodal Mantle Cell Lymphoma. [PDF]

Case Rep Hematol
Chiu J, Crowther M.
europepmc   +1 more source

FACS-Based Assessment of Human Hematopoietic Stem and Progenitor Cells. [PDF]

Int J Mol Sci
Schmachtel T, Bonig H, Rieger MA.
europepmc   +1 more source

Successful autologous CD19 CAR T cell therapy following severe lupus flare during immunosuppressive washout in refractory lupus nephritis. [PDF]

Lupus Sci Med
Gerber JM, Dehdashtian E, Hu G, Gregoire C, Borie D, Bindal P, Cerny J, Geara A, Schett G, Caricchio R.   +9 more
europepmc   +1 more source

Safety and efficacy of combined heparin/citrate anticoagulation for cell therapy collections in healthy adult allogeneic donors. [PDF]

Transfusion
Zhang J, Wu M, Racine-Brzostek S, Shayo S, Yazdanbakhsh K, Dormesy S, Shi PA.   +6 more
europepmc   +1 more source

Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas. [PDF]

Blood Neoplasia
Chavez JC, Napier E, Bondanza A, Lewandowski A, Mataraza J, Quinn D, Kwon P, Locke FL, Engels B, Awasthi R, Georgala P, Leyk M, Hynds D, Moschetta M, Schuster SJ.   +14 more
europepmc   +1 more source

Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis. [PDF]

Trials
Long EL, Stanway J, White M, Goudie N, Phillipson J, Morton M, Abdul Malek A, Brown P, Hide G, Jackson R, Nice C, Tuckett J, Diboll J, Anderson A, Pratt A, Hilkens CMU, Isaacs J.   +16 more
europepmc   +1 more source